GENMAB A/S (GMAB) Executive Compensation | rentseek.ing

GENMAB A/S(GMAB)

Analyzing alignment...

Based on 20-F filed 2025-12-01 · FY2025

How much does the CEO get paid?

FY2025 total compensation breakdown

Activity timeline · FY2025

Grants, governance, and insider moves

Recent events from filings

Grants Buys Sales Gifts/planned Governance

Dec 1, 2025
Deirdre P. Connelly — Restricted Stock Unit Vesting | Acquisition of 378 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Pernille Erenbjerg — Restricted Stock Unit Vesting | Acquisition of 283 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Anders Gersel Pedersen — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Mijke Zachariasse — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Martin Schultz — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Rolf Hoffmann — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Deirdre P. Connelly RSU (Grant FV $300)
Dec 1, 2025
Pernille Erenbjerg RSU (Grant FV $300)

Pay & Performance Snapshot

We need at least two years of pay and stock data to show the trend.

Is this pay justified?

Pay changes vs. stock performance

Are insiders buying or selling?

Recent insider trades by officers and directors

2 trades

Showing most recent insider activity (rolling 12 months from latest filing)

Insider Conviction Analysis

Are insiders selling into strength or holding through dips?

Insider Trading Activity

Insider transaction reports and planned sale notices for FY2024-FY2025 · through 2025-12-01

Company-wide activity · 2 filings

Company-wide activity Recent Activity

Showing FY2024-FY2025 insider trades across all insiders.

Klimovsky Judith V

Jun 17, 2025 · Planned sale· Value +$67,200

SEC filing →

Klimovsky Judith V

Mar 1, 2024 · Planned sale· Value +$330,000

SEC filing →

Top insiders by value sold

Within FY2024-FY2025 (ex tax withholding).

We need at least one realized sale to rank insiders.

Company-wide recent activity

Showing 2 of 2

Klimovsky Judith V

Jun 17, 2025 · Planned sale· Value +$67,200

SEC filing →

Klimovsky Judith V

Mar 1, 2024 · Planned sale· Value +$330,000

SEC filing →

All Executive Sales History

Full insider filing timeline across FY2024-FY2025. Use the filters below to explore other transaction types.

FY2024–FY2025

Compare insider activity →

Full data tables

For analysts and deep research

Show grant reconciliation, pay tables, and equity data

Grant Reconciliation

Want to know when GENMAB A/S files their next proxy?

Get one email when new executive compensation data is filed and processed.

Foreign Private Issuer compensation summary

GENMAB A/S reports as a Foreign Private Issuer. Instead of a standard executive pay table, the annual report provides narrative disclosure of executive compensation. Key excerpts are summarized below.

C. Interests of Experts and Counsel

Fiscal year 2024

C.
Interests of Experts and Counsel
Not applicable.
ITEM 8FINANCIAL INFORMATION
A.
Consolidated Statements and Other Financial Information
Financial Statements

E. Dilution

Fiscal year 2024

E.
Dilution
Not applicable.
F.
Expenses of the Issue
ITEM 10 ADDITIONAL INFORMATION
A.

B. Memorandum and Articles of Association

Fiscal year 2024

B.
Memorandum and Articles of Association
The sections entitled “Description of Share Capital and Certain Corporate Matters—Shareholders’ Register,” “Description of Share Capital and Certain Corporate Matters—Articles of Association and Danish Corporate Law” and “Description of Share Capital and Certain Corporate Matters—Comparison of Danish Corporate Law and our Articles of Association and Delaware Corporate Law” in the Company’s prospectus, filed with the SEC on July 19, 2019 are incorporated herein by reference.
Under the Danish foreign direct investment (“FDI”) Rules, a screening mechanism applies to foreign direct or indirect investments in certain sensitive sectors, if the foreign investor obtains at least 10% ownership or voting rights, or equivalent control by other means.
Among such sensitive sectors are companies and entities within critical infrastructure in Denmark that are necessary to maintain or restore the production, registration, distribution, and monitoring of prescription drugs.
If a contemplated foreign direct or indirect investment in Genmab A/S is considered to fall within the scope of the mandatory screening mechanism, the foreign investor is required to apply for prior authorization with the Danish Business Authority.
If a foreign investor fails to comply with the Danish FDI Rules, the Danish Business

Key figures

$: $50,000

F. Dividends and Paying Agents

Fiscal year 2024

F.
Dividends and Paying Agents
Not applicable.
G.
Statement by Experts
H.
Documents on Display

Key figures

Up to $: $0
(“ProfoundBio”) for USD: $1,720,000,000disclosed as millions or billions
Service Fees: $0

GENMAB A/S(GMAB)

Analyzing alignment...

Based on 20-F filed 2025-12-01 · FY2025

How much does the CEO get paid?

FY2025 total compensation breakdown

Activity timeline · FY2025

Grants, governance, and insider moves

Recent events from filings

Grants Buys Sales Gifts/planned Governance

Dec 1, 2025
Deirdre P. Connelly — Restricted Stock Unit Vesting | Acquisition of 378 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Pernille Erenbjerg — Restricted Stock Unit Vesting | Acquisition of 283 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Anders Gersel Pedersen — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Mijke Zachariasse — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Martin Schultz — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Rolf Hoffmann — Restricted Stock Unit Vesting | Acquisition of 189 shares due to vesting of restricted stock units.; Price per share: DKK2,043; Transaction occurred outside a market place.
Dec 1, 2025
Deirdre P. Connelly RSU (Grant FV $300)
Dec 1, 2025
Pernille Erenbjerg RSU (Grant FV $300)

Pay & Performance Snapshot

We need at least two years of pay and stock data to show the trend.

Is this pay justified?

Pay changes vs. stock performance

Are insiders buying or selling?

Recent insider trades by officers and directors

2 trades

Showing most recent insider activity (rolling 12 months from latest filing)

Insider Conviction Analysis

Are insiders selling into strength or holding through dips?

Insider Trading Activity

Insider transaction reports and planned sale notices for FY2024-FY2025 · through 2025-12-01

Company-wide activity · 2 filings

Company-wide activity Recent Activity

Showing FY2024-FY2025 insider trades across all insiders.

Klimovsky Judith V

Jun 17, 2025 · Planned sale· Value +$67,200

SEC filing →

Klimovsky Judith V

Mar 1, 2024 · Planned sale· Value +$330,000

SEC filing →

Top insiders by value sold

Within FY2024-FY2025 (ex tax withholding).

We need at least one realized sale to rank insiders.

Company-wide recent activity

Showing 2 of 2

Klimovsky Judith V

Jun 17, 2025 · Planned sale· Value +$67,200

SEC filing →

Klimovsky Judith V

Mar 1, 2024 · Planned sale· Value +$330,000

SEC filing →

All Executive Sales History

Full insider filing timeline across FY2024-FY2025. Use the filters below to explore other transaction types.

FY2024–FY2025

Compare insider activity →

Full data tables

For analysts and deep research

Show grant reconciliation, pay tables, and equity data

Grant Reconciliation

Want to know when GENMAB A/S files their next proxy?

Get one email when new executive compensation data is filed and processed.

Foreign Private Issuer compensation summary

C. Interests of Experts and Counsel

Fiscal year 2024

C.
Interests of Experts and Counsel
Not applicable.
ITEM 8FINANCIAL INFORMATION
A.
Consolidated Statements and Other Financial Information
Financial Statements

E. Dilution

Fiscal year 2024

E.
Dilution
Not applicable.
F.
Expenses of the Issue
ITEM 10 ADDITIONAL INFORMATION
A.

B. Memorandum and Articles of Association

Fiscal year 2024

B.
Memorandum and Articles of Association
The sections entitled “Description of Share Capital and Certain Corporate Matters—Shareholders’ Register,” “Description of Share Capital and Certain Corporate Matters—Articles of Association and Danish Corporate Law” and “Description of Share Capital and Certain Corporate Matters—Comparison of Danish Corporate Law and our Articles of Association and Delaware Corporate Law” in the Company’s prospectus, filed with the SEC on July 19, 2019 are incorporated herein by reference.
Under the Danish foreign direct investment (“FDI”) Rules, a screening mechanism applies to foreign direct or indirect investments in certain sensitive sectors, if the foreign investor obtains at least 10% ownership or voting rights, or equivalent control by other means.
Among such sensitive sectors are companies and entities within critical infrastructure in Denmark that are necessary to maintain or restore the production, registration, distribution, and monitoring of prescription drugs.
If a contemplated foreign direct or indirect investment in Genmab A/S is considered to fall within the scope of the mandatory screening mechanism, the foreign investor is required to apply for prior authorization with the Danish Business Authority.
If a foreign investor fails to comply with the Danish FDI Rules, the Danish Business

Key figures

$: $50,000

F. Dividends and Paying Agents

Fiscal year 2024

F.
Dividends and Paying Agents
Not applicable.
G.
Statement by Experts
H.
Documents on Display

Key figures

Up to $: $0
(“ProfoundBio”) for USD: $1,720,000,000disclosed as millions or billions
Service Fees: $0

How much does the CEO get paid?

Grants, governance, and insider moves

Pay & Performance Snapshot

Is this pay justified?

Are insiders buying or selling?

Insider Trading Activity

Company-wide activity Recent Activity

Company-Wide ActivityAll insider filings across the organization for FY2024-FY2025.

Company-Wide Activity

Top insiders by value sold

Company-wide recent activity

All Executive Sales History

Full data tables

Grant Reconciliation

Want to know when GENMAB A/S files their next proxy?

Foreign Private Issuer compensation summary

C. Interests of Experts and Counsel

E. Dilution

B. Memorandum and Articles of Association

Key figures

F. Dividends and Paying Agents

Key figures

How much does the CEO get paid?

Grants, governance, and insider moves

Pay & Performance Snapshot

Is this pay justified?

Are insiders buying or selling?

Insider Trading Activity

Company-wide activity Recent Activity

Company-Wide ActivityAll insider filings across the organization for FY2024-FY2025.

Company-Wide Activity

Top insiders by value sold

Company-wide recent activity

All Executive Sales History

Full data tables

Grant Reconciliation

Want to know when GENMAB A/S files their next proxy?

Foreign Private Issuer compensation summary

C. Interests of Experts and Counsel

E. Dilution

B. Memorandum and Articles of Association

Key figures

F. Dividends and Paying Agents

Key figures